Logo Logo
2202 State Ave, Panama City, FL 32405
850-215-7071

Mariusz Klin, M.D., Ph.D

Solesta Injections

Special note: Dr. Klin is the only physician in the area who treats incontinence in this manner and is trained to administer SOLESTA.

What is SOLESTA and what is it used to treat?
Solesta is a treatment for the loss of bowel control, also known as Fecal Incontinence. Fecal Incontinence is more common than you may think. Unfortunately, millions of people suffer every day from accidents and leaks, but Solesta can help. These injections are given in Dr. Klin’s office and are proven to help reduce accidents.

Are there things you can do prior to asking for Solesta treatments?
Yes, Solesta is only for people who have not had relief from

  • Changes in diet
  • Exercise
  • Drugs that soften the stool
  • Drugs meant to slow down the digestive process.
Solesta is an option only after simple methods have failed, but BEFORE you consider undergoing surgery.

How does Solesta work?
Solesta is a gel that is given through four (4) injections into the wall of the anal canal. It helps give you more control by bulking up the tissue in the anal canal. Since the injections are well tolerated by most patients, anesthesia is not necessary.

Solesta is composed of naturally made materials similar to the natural starches, sugars, and tissue in your body.

NOTE: Solesta is indicated for the treatment of Fecal Incontinence in patients 18 years and older who have failed conservative therapy.

What is involved with a Solesta treatment?
This is a quick, nonsurgical outpatient procedure.

  • The Solesta treatment procedure is done in the office.
  • No anesthesia is required.
  • You may resume limited physical activity immediately after the procedure.
  • You can resume a normal lifestyle and all physical activities after one week.
  • Solesta may begin working soon after the procedure, with optimal results at three months for most patients.
  • The effectiveness of Solesta continues over time. Solesta was shown to be effective in patients for two years, and patients’ results are still being followed for a three-year period.

Source: Salix Pharmaceuticals
Return to list